-
-
-
-
-
-
-
LifeMD Appoints Umesh Sripad as Chief Technology Officer
-
-
-
-
-
-
-
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
-
-
-
-
-
-
-
LifeMD, Inc. (LFMD) Tops Q4 EPS by 3c, provides guidance
-
-
-
-
-
-
-
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
-
-
-
-
-
-
-
LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17
-
-
-
-
-
-
-
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
-
-
-
-
-
-
-
LifeMD Names COO and Promotes Two Executives
-
1,218,608 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

